Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction

Close to 20% of cancer patients currently use nicotine products. Nicotine use in breast cancer patients is associated with poorer overall outcomes, including worsened survival and increased surgical complications. Nicotine cessation is rarely addressed in breast cancer patients at the time of diagnosis and may be a missed opportunity to optimize patient outcomes. Patients that use nicotine products are not offered reconstruction at time of mastectomy or oncoplastics at the time of lumpectomy, which can be emotionally distressing in women with breast cancer. Reconstruction could be an additiona

Trial Details

NCT ID
NCT06461650
Phase
NA
Sponsor
University of Florida
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Nicotine cessation program
Locations (sample)
  • Gainesville, Florida, United States|29.65163,-82.32483

Key Eligibility Criteria

  • Adults ≥ 18 years of age and ≤ 80 years of age.
  • Women who are diagnosed with Stage 0 - 3 breast cancer confirmed by biopsy
  • Women who have been recommended to have reconstruction at time of mastectomy or oncoplastics at time of lumpectomy
  • Participants who actively use nicotine products defined as any self-reported nicotine use within the past month

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →